Immunicum AB (publ) Announces Appointment of Peter Hein as Interim Chief Financial Officer
Keep reading
Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology
